Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ: RXRX )

10.35 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 157,390
Open 10.35
Bid (Size) 10.17 (16)
Ask (Size) 10.19 (72)
Prev. Close 10.35
Today's Range 10.35 - 10.35
52wk Range 5.600 - 15.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SoundHound and Serve Robotics Are Dropping Like a Rock -- Why Nvidia Was the Catalyst
Nvidia sold their stake in some high-flying stocks recently. 
Via The Motley Fool
Altitude Lab Launches Pre-seed Venture Fund, Anchored by Recursion CEO Chris Gibson, Enabling SBIR-awarded Biotechs Hit by Funding Gap to Build in Salt Lake City
The Altitude Lab Fund aims to deliver strong returns to Limited Partners, accelerate the growth of Salt Lake City’s Life Science hub, and enable high potential startups support while federal funding is... 
From Recursion Pharmaceuticals
Via GlobeNewswire

Performance

YTD
+43.55%
+43.55%
1 Month
+50.44%
+50.44%
3 Month
+80.00%
+80.00%
6 Month
+40.82%
+40.82%
1 Year
-16.33%
-16.33%

More News

Read More
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Where Recursion Pharmaceuticals Stands With Analysts
Via Benzinga
How Is The Market Feeling About Recursion Pharmaceuticals?
Via Benzinga
Altitude Lab Startups Raise $154M in Capital
From Recursion Pharmaceuticals
Via GlobeNewswire
25 Top AI Stocks That Could Boost Your Portfolio
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Is Recursion Pharmaceuticals Stock a Buy?
Via The Motley Fool
SoftBank Joins Nvidia In Backing Recursion Pharma, Retail Traders Rally Behind Stock Surge
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Recursion Pharmaceuticals Stock Is Soaring Today
Via The Motley Fool
Nvidia Invests in These 2 Artificial Intelligence (AI) Stocks and Sells These 3 Others
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why SoundHound AI and Serve Robotics Stock Crashed on Friday
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia Dumps SoundHound, Trims Arm Stake, Buys These 2 Stocks
Via Investor's Business Daily
Biotechs on the Brink: 2 Stocks With Huge Potential
Via MarketBeat
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference
From Recursion Pharmaceuticals, Inc.
Via GlobeNewswire
3 Monster Stocks to Hold for the Next 10 Years
Via The Motley Fool
AI Pharma: 2 Paths to AI-Powered Drug Investment
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia-Backed Recursion Pharma Hits 3-Week High, Sparks Retail Buzz Amid Broader AI Hype
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
2 Growth Stocks That Could Rocket Higher in the First Quarter of 2025
Via The Motley Fool
AI Drug Discovery Startups: Analysis Of Exscientia’s Acquisition By Recursion
Via Talk Markets
Topics Artificial Intelligence Stocks / Equities
Exposures Artificial Intelligence
Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce
Via Benzinga
Topics Workforce
Exposures Layoff
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.